Bone-targeted erythrocyte-cancer hybrid membrane-camouflaged nanoparticles for enhancing photothermal and hypoxia-activated chemotherapy of bone invasion by OSCC.
Hongying ChenJiang DengXintong YaoYungang HeHanyue LiZhixiang JianYi TangXiaoqing ZhangJingqing ZhangHong-Wei DaiPublished in: Journal of nanobiotechnology (2021)
Asp8[H40-TPZ/IR780@(RBC-H)] has bone targeting, tumor-homing and immune escape abilities, therefore, it is an efficient multi-targeting drug delivery platform for achieving precise anti-cancer therapy during bone invasion.
Keyphrases
- cancer therapy
- drug delivery
- bone mineral density
- soft tissue
- bone loss
- bone regeneration
- cell migration
- postmenopausal women
- endothelial cells
- squamous cell carcinoma
- drug release
- papillary thyroid
- photodynamic therapy
- radiation therapy
- single cell
- locally advanced
- squamous cell
- lymph node metastasis
- walled carbon nanotubes